Personalized vaccine helps patients fight ovarian cancer
In early research that extends the possibilities of immunotherapy to a disease feared by women, a personalized vaccine helped patients with ovarian cancer mount a stronger defense against their tumors and substantially improved their survival rate.
The vaccine was tested in a preliminary clinical trial and used with standard chemotherapy and an immune-boosting agent.
The experimental therapy, described in the journal
